Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_assertion type Assertion NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_head.
- NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_assertion description "[Furthermore, the haplotype carrying the risk-conferring 3'UTR-8494 variant was associated with a 35% increase in the odds for adenoma incidence in males (OR=1.35, CI: 1.07-1.70), but the one with a risk allele at 3'UTR-8494 and a protective allele at intron 5-5229 had no effect on adenoma development (OR=0.85, CI: 0.66-1.09).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_provenance.
- NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_assertion evidence source_evidence_literature NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_provenance.
- NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_assertion SIO_000772 16205694 NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_provenance.
- NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_assertion wasDerivedFrom befree-20140225 NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_provenance.
- NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_assertion wasGeneratedBy ECO_0000203 NP650861.RAvHDCTDGK9Ef3_qVzdMLVApQt1zi3VxDmjeuL2T4ijxk130_provenance.